Benzo[a]pyrene—Environmental Occurrence, Human Exposure, and Mechanisms of Toxicity

B Bukowska, K Mokra, J Michałowicz - International Journal of Molecular …, 2022 - mdpi.com
Benzo [a] pyrene (B [a] P) is the main representative of polycyclic aromatic hydrocarbons
(PAHs), and has been repeatedly found in the air, surface water, soil, and sediments. It is …

Mutant p53 in cancer: from molecular mechanism to therapeutic modulation

X Chen, T Zhang, W Su, Z Dou, D Zhao, X Jin… - Cell Death & …, 2022 - nature.com
TP53, a crucial tumor suppressor gene, is the most commonly mutated gene in human
cancers. Aside from losing its tumor suppressor function, mutant p53 (mutp53) often …

[PDF][PDF] Genomic features of response to combination immunotherapy in patients with advanced non-small-cell lung cancer

MD Hellmann, T Nathanson, H Rizvi, BC Creelan… - Cancer cell, 2018 - cell.com
Combination immune checkpoint blockade has demonstrated promising benefit in lung
cancer, but predictors of response to combination therapy are unknown. Using whole-exome …

Clonal expansion in non-cancer tissues

N Kakiuchi, S Ogawa - Nature Reviews Cancer, 2021 - nature.com
Cancer is a clonal disorder derived from a single ancestor cell and its progenies that are
positively selected by acquisition of 'driver mutations'. However, the evolution of positively …

Cancer multidrug-resistance reversal by ABCB1 inhibition: A recent update

K Engle, G Kumar - European Journal of Medicinal Chemistry, 2022 - Elsevier
Chemotherapy is one of the most common treatments for cancer that uses one or more anti-
cancer drugs as a part of the standardized chemotherapy regimen. Cytotoxic chemicals …

Tobacco smoking and somatic mutations in human bronchial epithelium

K Yoshida, KHC Gowers, H Lee-Six… - Nature, 2020 - nature.com
Tobacco smoking causes lung cancer,–, a process that is driven by more than 60
carcinogens in cigarette smoke that directly damage and mutate DNA,. The profound effects …

[PDF][PDF] A compendium of mutational signatures of environmental agents

JE Kucab, X Zou, S Morganella, M Joel, AS Nanda… - Cell, 2019 - cell.com
Summary Whole-genome-sequencing (WGS) of human tumors has revealed distinct
mutation patterns that hint at the causative origins of cancer. We examined mutational …

Potential Predictive Value of TP53 and KRAS Mutation Status for Response to PD-1 Blockade Immunotherapy in Lung Adenocarcinoma

ZY Dong, WZ Zhong, XC Zhang, J Su, Z Xie, SY Liu… - Clinical cancer …, 2017 - AACR
Purpose: Although clinical studies have shown promise for targeting programmed cell death
protein-1 (PD-1) and ligand (PD-L1) signaling in non–small cell lung cancer (NSCLC), the …

Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer

NA Rizvi, MD Hellmann, A Snyder, P Kvistborg… - Science, 2015 - science.org
Immune checkpoint inhibitors, which unleash a patient's own T cells to kill tumors, are
revolutionizing cancer treatment. To unravel the genomic determinants of response to this …

TP53 Variations in Human Cancers: New Lessons from the IARC TP53 Database and Genomics Data

L Bouaoun, D Sonkin, M Ardin, M Hollstein… - Human …, 2016 - Wiley Online Library
ABSTRACT TP53 gene mutations are one of the most frequent somatic events in cancer.
The IARC TP53 Database (http://p53. iarc. fr) is a popular resource that compiles occurrence …